Related Experiment Video
Updated: Jun 5, 2026

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
Published on: April 21, 2017
Pharmacology in childhood arterial ischemic stroke
Catherine Amlie-Lefond1, Joan Cox Gill
1Department of Neurology, Medical College of Wisconsin, Milwaukee, WI 53201, USA. KLefond@mcw.edu
Abstract:
In recent years, there has been increasing recognition of the impact of childhood stroke and interest in the role of drugs in the acute, chronic, and prophylactic management of this condition. Most treatment strategies are based on studies in adults with stroke, and the relative infrequency of stroke and the heterogeneity of etiologies in childhood compared with adults present significant challenges in study design for childhood stroke studies. The presence of thrombophilia has been associated with stroke in children, strengthening the concept that antithrombotic, antiplatelet, and even thrombolytic agents have a role in stroke treatment and prevention. There are several potential roles for drugs in the treatment of childhood stroke including hyperacute therapy, antithrombotic medication, antiplatelet medication, and disease-specific medications. Herein, we review the use and rationale of these medications in childhood arterial ischemic stroke.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Ischemic Stroke l: Introduction
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Hemorrhagic Stroke ll: Pathophysiology

